Recent research focusing on Tirzepatide at a dosage of 20mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may boost the drug's ability to control blood levels, potentially offering more significant outcomes for individuals with insulin resistance. Further research is underway to fully understand